Published on 9 Nov 2024 on GuruFocus.com · via Yahoo Finance
Lantern Pharma Inc (LTRN) Q3 2024 Earnings Call Highlights: Strategic Advances...
Net Loss: Approximately $4.5 million for Q3 2024, or $0.42 per share, compared to $3.2 million or...
NASDAQ.LTRN price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free